European Journal of Heart Failure

OCTOBER 9, 2023

Impact of COVID-19 in patients with HF and mildly reduced and preserved ejection fraction. COVID-19, coronvirus disease-2019; HF, heart failure. Aim COVID-19 may affect clinical risk in patients with heart failure. DELIVER began before and was conducted during the COVID-19 pandemic. 95% CI 130.3–180.8)

Preserved Ejection Fraction 40

Preserved Ejection Fraction COVID-19 Heart Failure Hospital 40

Open Heart

SEPTEMBER 19, 2023

Background The COVID-19 pandemic disrupted the continuing management of cardiovascular disease (CVD) risk factors in the population. Whether the COVID-19 pandemic increased, the SES gap in CVD risk factors is unknown. years) the COVID-19 pandemic. Socioeconomic status (SES) is a major determinant of health.

COVID-19 40

COVID-19 Risk Factors Hypertension Diabetes 40

DAIC

APRIL 9, 2024

The international ARISE-HF trial was designed to test the effectiveness of the investigational drug AT-001 at stabilizing exercise capacity in patients with diabetic cardiomyopathy. Patients had had Type 2 diabetes for an average of 14 years. Decline in exercise ability is a hallmark of progression to overt heart failure.

Heart Failure 52

Heart Failure Diabetes Cardiomyopathy Exercise 52

American College of Cardiology

AUGUST 30, 2024

Semaglutide, the popular anti-obesity medication originally developed to treat diabetes, continues to show cardiovascular benefits beyond weight loss, including reducing risk of death, reducing serious COVID-19-related events and improving heart failure (HF) symptoms, according to six new substudies published in JACC.

COVID-19 40

COVID-19 Obesity Heart Failure Outcomes 40

Journal of the American Heart Association

DECEMBER 12, 2023

We calculated total patients with potentially undiagnosed hypertension and compared patients flagged for undiagnosed hypertension to those with diagnosed hypertension and to the full patient panel across individual characteristics, clinical and health system factors (eg, clinic of care), and timing.

Hypertension 45

Hypertension COVID-19 Medicaid Medicare 45

Dr. Smith's ECG Blog

NOVEMBER 12, 2020

This is a 30-something healthy patient presented with COVID pneumonia who presented to the ED. An elevated troponin in a COVID patient confers about 4x the risk of mortality than a normal one. Beware elevated troponins in COVID patients. He was moderately hypoxic. There is minimal, probably normal STE in V2-V6. 3–8 Shi et al.

Cardiac Arrest 52

Cardiac Arrest COVID-19 Myocardial Infarction Cardiogenic Shock 52

DAIC

APRIL 6, 2024

SGLT-2 inhibitors were initially approved to treat Type 2 diabetes by lowering blood sugar. About 32% had Type 2 diabetes. This finding is completely consistent in both direction and magnitude with other studies of SGLT-2 inhibitors in populations with diabetes and chronic kidney disease.”

Heart attacks 98

Heart attacks Heart Attack Heart Failure Outpatient 98

DAIC

APRIL 30, 2024

The drug, dapagliflozin, was initially approved for the treatment of Type 2 diabetes, but it since has been shown to reduce the risk of hospitalization for heart failure and death in patients with serious health problems that include heart and chronic kidney disease and heightened cardiovascular risk.

Heart Failure 105

Heart Failure Hospital Research COVID-19 105

DAIC

APRIL 6, 2024

SGLT-2 inhibitors were initially approved to treat Type 2 diabetes by lowering blood sugar. About 32% had Type 2 diabetes. This finding is completely consistent in both direction and magnitude with other studies of SGLT-2 inhibitors in populations with diabetes and chronic kidney disease.”

Heart attacks 81

Heart attacks Heart Attack Heart Failure Outcomes 81

Circulation: Cardiovascular Quality & Outcomes

NOVEMBER 6, 2023

Background:Low-income working-age US adults disproportionately experienced healthcare disruptions at the onset of the COVID-19 pandemic. 0.96]) decreased for low-income adults, while diabetes screening (RR 1.01 [0.95-1.08]) 1.08]) increased and diabetes focused visits and insulin use remained stable.

Risk Factors 40

Risk Factors Medicaid COVID-19 Outpatient 40

Dr. Malcolm Kendrick

JANUARY 30, 2023

31st January 2023 With the resignation of Jacinda Ardern, my thoughts were dragged back to Covid once more. But it got me thinking about lockdowns again and the whole worldwide madness of Covid. During the Covid pandemic I travelled far past angry, to reach a point of utter weariness. Not just from Covid, but from everything.

COVID-19 52

COVID-19 Article Nursing Cancer 52

European Journal of Heart Failure

MARCH 4, 2024

Prior studies were able to show that sodium–glucose cotransporter 2 inhibitors may reduce the incidence of LRTI in patients with type 2 diabetes. No effect of empagliflozin was observed on COVID-19 incidence. Cox regression was used to study the effect of empagliflozin on incident LRTI. Patients who developed LRTI had a 2.7-fold

Preserved Ejection Fraction 40

Preserved Ejection Fraction Heart Failure COVID-19 Kidney Disease 40

Dr. Sanjay Gupta

AUGUST 31, 2022

Only 10% of patients with COVID develop Long COVID – why? If it were just something about the virus then surely everyone who got COVID would be expected to get long COVID. The severity of COVID does not have a bearing on whether you get Long COVID or not. Are POTS AND LongCOVID the same condition?

POTS 40

POTS Quality of Life Tachycardia COVID-19 40

Frontiers in Cardiovascular Medicine

JANUARY 13, 2025

IntroductionThe COVID-19 pandemic, starting in 2020, raised concerns about potential long-term health impacts, including its effects on cardiovascular health and related biomarkers. The prevalence and treatment rates of diabetes, hypertension, and dyslipidemia remained consistent.

COVID-19 52

COVID-19 Blood Pressure Cholesterol Biomarkers 52

Physiologically Speaking

APRIL 24, 2024

6 [link] Insufficient sleep has been linked to a greater risk for several health conditions including obesity, diabetes, hypertension, and cognitive decline. 7 8 Sleep may have also played an underemphasized role in the COVID-19 pandemic. More than one-third of U.S.

Blood Pressure 52

Blood Pressure Blood Clot COVID-19 Cardiovascular Disease 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Mark Erfe Outcomes of Sutureless/Rapid Deployment Valves Compared to Traditional Bioprosthetic Aortic Valves The Annals of Thoracic Surgery September 2020 J.

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori 1 Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion 2 Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Frontiers in Cardiovascular Medicine

FEBRUARY 17, 2025

Individuals with myocardial injury had a higher prevalence of hypertension, diabetes, and dyslipidemia. This multicenter study uniquely represents data from 13 Latin American countries, offering regional insights into the impact of myocardial injury during the COVID-19 pandemic. Survival probability was lower in this subgroup.

COVID-19 40

COVID-19 Hospital Kidney Disease Heart Failure 40